S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
S&P 500   4,513.04
DOW   34,022.04
QQQ   387.12
NASDAQ:DALS

DA32 Life Science Tech Acquisition Stock Forecast, Price & News

$9.84
0.00 (0.00%)
(As of 12/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.84
$9.84
50-Day Range
$9.68
$10.26
52-Week Range
$9.66
$10.26
Volume
N/A
Average Volume
7,296 shs
Market Capitalization
$252.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive DALS News and Ratings via Email

Sign-up to receive the latest news and ratings for DA32 Life Science Tech Acquisition and its competitors with MarketBeat's FREE daily newsletter.


About DA32 Life Science Tech Acquisition

DA32 Life Science Tech Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. DA32 Life Science Tech Acquisition Corp. is based in New York.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:DALS
Web
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$252.40 million
Optionable
Not Optionable

Company Calendar

Today
12/02/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

0.00 out of 5 stars

Unclassified Sector

403rd out of 558 stocks

Holding & Other Investment Offices Industry

381st out of 518 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












DA32 Life Science Tech Acquisition (NASDAQ:DALS) Frequently Asked Questions

Are investors shorting DA32 Life Science Tech Acquisition?

DA32 Life Science Tech Acquisition saw a decrease in short interest in October. As of October 29th, there was short interest totaling 14,200 shares, a decrease of 23.7% from the October 14th total of 18,600 shares. Based on an average daily trading volume, of 14,500 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.1% of the shares of the company are sold short.
View DA32 Life Science Tech Acquisition's Short Interest
.

When did DA32 Life Science Tech Acquisition IPO?

(DALS) raised $200 million in an initial public offering on Wednesday, July 28th 2021. The company issued 20,000,000 shares at $10.00 per share.

What is DA32 Life Science Tech Acquisition's stock symbol?

DA32 Life Science Tech Acquisition trades on the NASDAQ under the ticker symbol "DALS."

When does the company's lock-up period expire?

DA32 Life Science Tech Acquisition's lock-up period expires on Monday, January 24th. DA32 Life Science Tech Acquisition had issued 20,000,000 shares in its public offering on July 28th. The total size of the offering was $200,000,000 based on an initial share price of $10.00. After the expiration of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Who are DA32 Life Science Tech Acquisition's major shareholders?

DA32 Life Science Tech Acquisition's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wellington Management Group LLP (12.07%), Deerfield Management Company L.P. Series C (6.24%), BlackRock Inc. (5.85%), RA Capital Management L.P. (5.85%), Magnetar Financial LLC (3.63%) and Millennium Management LLC (3.52%).

Which institutional investors are buying DA32 Life Science Tech Acquisition stock?

DALS stock was purchased by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, Deerfield Management Company L.P. Series C, RA Capital Management L.P., BlackRock Inc., Magnetar Financial LLC, Millennium Management LLC, Moore Capital Management LP, and Citadel Advisors LLC.

How do I buy shares of DA32 Life Science Tech Acquisition?

Shares of DALS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DA32 Life Science Tech Acquisition's stock price today?

One share of DALS stock can currently be purchased for approximately $9.84.

How much money does DA32 Life Science Tech Acquisition make?

DA32 Life Science Tech Acquisition has a market capitalization of $252.40 million.

How many employees does DA32 Life Science Tech Acquisition have?

DA32 Life Science Tech Acquisition employs 2,021 workers across the globe.

How can I contact DA32 Life Science Tech Acquisition?

The company can be reached via phone at 212551600.


This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.